Lista de obras - Jurjen Tel - Dominio Público Uruguay

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

artículo científico

Abstract IA29: Towards synthetic immune cells for cancer immunotherapy

An electro-coalescence chip for effective emulsion breaking in droplet microfluidics

artículo científico publicado en 2014

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

artículo científico publicado en 2013

CD56 marks human dendritic cell subsets with cytotoxic potential

artículo científico publicado en 2013

CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.

artículo científico publicado en 2016

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis

scientific article published on 01 February 2016

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses

artículo científico

Cross-talk between human dendritic cell subsets influences expression of RNA sensors and inhibits picornavirus infection

artículo científico publicado en 2010

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

artículo científico

DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells

scientific article published on 17 March 2011

Deciphering the message broadcast by tumor-infiltrating dendritic cells

artículo científico

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

artículo científico publicado en 2016

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Harnessing human plasmacytoid dendritic cells as professional APCs.

artículo científico

Human Plasmacytoid Dendritic Cells Phagocytose, Process, and Present Exogenous Particulate Antigen

artículo científico publicado en 2010

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

artículo científico publicado en 2012

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

artículo científico publicado en 2012

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.

artículo científico publicado en 2010

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

artículo científico publicado en 2012

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

artículo científico publicado en 2015

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

article

Naturally circulating dendritic cells to vaccinate cancer patients.

artículo científico publicado en 2013

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

artículo científico publicado en 2015

Polymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses

article

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.

artículo científico publicado en 2012

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.

artículo científico publicado en 2016

Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics.

artículo científico publicado en 2013

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

artículo científico publicado en 2011

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

artículo científico publicado en 2015

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

artículo científico publicado en 2016

Selective Expression of the MAPK Phosphatase Dusp9/MKP-4 in Mouse Plasmacytoid Dendritic Cells and Regulation of IFN-β Production

artículo científico publicado en 2015

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

artículo científico publicado en 2018

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.

artículo científico publicado en 2012

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

artículo científico publicado en 2013

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

scientific article published on 10 January 2012

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

artículo científico publicado en 2011

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

artículo científico publicado en 2010

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.

artículo científico publicado en 2014

Tumoricidal activity of human dendritic cells.

artículo científico publicado en 2013

Lista de obras de Jurjen Tel

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

Abstract IA29: Towards synthetic immune cells for cancer immunotherapy

An electro-coalescence chip for effective emulsion breaking in droplet microfluidics

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

CD56 marks human dendritic cell subsets with cytotoxic potential

CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses

Cross-talk between human dendritic cell subsets influences expression of RNA sensors and inhibits picornavirus infection

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells

Deciphering the message broadcast by tumor-infiltrating dendritic cells

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Harnessing human plasmacytoid dendritic cells as professional APCs.

Human Plasmacytoid Dendritic Cells Phagocytose, Process, and Present Exogenous Particulate Antigen

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

Naturally circulating dendritic cells to vaccinate cancer patients.

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

Polymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition.

Probing cellular heterogeneity in cytokine-secreting immune cells using droplet-based microfluidics.

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

Selective Expression of the MAPK Phosphatase Dusp9/MKP-4 in Mouse Plasmacytoid Dendritic Cells and Regulation of IFN-β Production

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

Targeted delivery of CpG ODN to CD32 on human and monkey plasmacytoid dendritic cells augments IFNα secretion.

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.

Tumoricidal activity of human dendritic cells.